ANDREA ZOCKOLL: Open Payments
NPI 1881054989 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 13 payments from 12 companies in 2025. Trend: 2023 $486 · 2024 $400 · 2025 $348
Food & beverage: $327Education: $22
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $43 |
| Gilead Sciences, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: MAVYRET, Veozah, Dexcom G6 Transmitter, RAYALDEE, Wegovy, GEMTESA, APTIMA, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
